FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

ULTRAGENYX PHARMACEUTICAL INC.: accounts_receivable

One fact, its scope and the complete path back to the official record.

Period: as of 2022-06-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/5ecd210e-5be4-4be5-81d4-83327524c37d

Reported value

$37.207M{"amount": 37207000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Entity
ULTRAGENYX PHARMACEUTICAL INC.
Metric
accounts_receivable
Period
as of 2022-06-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-22-013411 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:13:48.701378+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001515673/accounts-receivable/2022-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.